Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

NCT01349361 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT01349361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01349361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
Lead sponsor
Bispebjerg Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2011
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinomas, photodynamic therapy